Opko Health OPK
NASDAQ OPK
$1.64 +0.01 (+0.61%)
As of: Oct 23, 2026 · 1:30 PM EDT

Opko Health (OPK) Non-Current Deffered Revenue (2022 - 2024)

Updated

Opko Health (OPK) recorded Non-Current Deffered Revenue of $7,000 in Q3 2024, down 94.9% from $136,000 a year earlier and unchanged from the prior quarter.

Analysis

Opko Health (OPK) Non-Current Deffered Revenue (2022 - 2024) Analysis & Trends

Starting with Q4 2022, Opko Health's Non-Current Deffered Revenue history includes 7 quarters.

  • Across earlier years, Non-Current Deffered Revenue came in at $138,000 in FY2022.
  • Quarterly Non-Current Deffered Revenue has ranged from $7,000 in Q4 2023 to $140,000 in Q2 2023 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $7,000 (Q2 2024), $7,000 (Q1 2024) and $7,000 (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,138.00 Bn 1,106.58 Bn 19.71 Bn -
2 Johnson & Johnson 634.40 Bn 554.26 Bn 17.30 Bn -
3 AbbVie 506.36 Bn 479.47 Bn 12.70 Bn -
4 Merck 358.30 Bn 312.68 Bn 12.21 Bn -
5 Novartis Ag 293.12 Bn 257.11 Bn 11.24 Bn -
6 Astrazeneca 265.36 Bn 239.05 Bn 12.86 Bn -
7 Amgen 238.40 Bn 193.80 Bn 7.24 Bn -
8 Gilead Sciences 195.15 Bn 169.35 Bn 6.22 Bn -
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn -
10 Opko Health 1.24 Bn -188.28 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 7,000.00
Jun 30, 2024 7,000.00
Mar 31, 2024 7,000.00
Dec 31, 2023 7,000.00
Sep 30, 2023 136,000.00
Jun 30, 2023 140,000.00
Dec 31, 2022 138,000.00
API Access

Opko Health Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=OPK&period=max&api_key=YOUR_API_KEY